Living with HIV involves more than just taking medication—it's about managing your health day-to-day, often while facing stigma. A new study tested whether a special program could help. Researchers worked with 64 Thai men who have sex with men and are living with HIV. Half received their usual care, while the other half also joined a culturally adapted program: four group sessions over seven weeks, led by a nurse and supported by peers. The goal was to build skills and confidence in managing their HIV. After 12 weeks, the men in the program showed greater improvements than the usual-care group. Their CD4 counts (a key measure of immune health) improved more, they reported better adherence to their antiretroviral therapy (ART), their quality of life scores went up, and they felt more capable of managing their HIV. No one reported any harm from the program. This is encouraging—it suggests that adding this kind of supportive, group-based learning to routine care could make a real difference in how people live with HIV. But it's important to keep these results in perspective. The study was small, and we only saw what happened over three months. We don't know if these improvements last longer, or if they translate into harder health outcomes like keeping the virus fully suppressed. The study also didn't detail exactly how they measured medication adherence. So, while this program shows real promise as a potential model, especially in places with limited resources, we need larger studies that follow people for longer to know how well it truly works.
Nurse-led peer-supported education improves CD4 count and adherence in Thai MSM with HIVCan group support help men with HIV manage their health better?
AI-generated summary of the cited source, checked by automated accuracy review. How we work
In a randomized controlled trial, 64 Thai men who have sex with men (MSM) living with HIV at a tertiary clinic in Thailand were assigned to receive either the HIV/AIDS Self-Management Education Program-Thai (HASMEP-T) plus routine care or routine care only. HASMEP-T is a culturally adapted, nurse-delivered, peer-supported intervention consisting of four biweekly, 3-hour group sessions over 7 weeks.
At the 12-week follow-up, the intervention group showed significantly greater improvements than the control group across all measured secondary outcomes. CD4 count improved by an additional 84.5 cells/mm³ (p < 0.05), ART adherence improved by an additional 8.9% (p < 0.05), quality of life (WHOQOL-BREF) improved by an additional 14.7 points (p < 0.05), and HIV self-management improved by an additional 9.1 points (p < 0.05). The study reported no adverse events.
Key limitations include the small sample size (n=64), short 12-week follow-up period, and lack of reported long-term or clinical outcomes such as viral suppression, morbidity, or mortality. The method for measuring ART adherence and detailed baseline characteristics were not reported. The RCT design supports causal inference for the intervention's effect on the measured outcomes, but the findings are from a single, small trial.
This culturally adapted program has the potential to be integrated into routine HIV care to strengthen adherence and improve quality of life in resource-limited settings. However, its clinical relevance is restrained by the study's scale, duration, and focus on surrogate markers rather than hard clinical endpoints.